Early antibiotic exposure and vaccine immune responses in preterm infants: potential sex-specific differences

Laura Haag1, Stefanie Dietz-Ziegler1,2, Julian Schwarz1

  • 1Department of Neonatology, Tuebingen University Children's Hospital, Tuebingen, Germany.

Gut Microbes
|June 27, 2026
PubMed

Insights

Early antibiotic exposure in preterm infants can impair vaccine responses, particularly in girls. This may be linked to microbiome and immune cell changes, affecting immune development.

Area of Science:

  • Neonatal immunology
  • Microbiome research
  • Vaccinology

Background:

  • Neonatal sepsis is a significant risk for preterm infants, often leading to early antibiotic use.
  • The effects of early antibiotics on preterm immune development are not well understood, unlike in term-born neonates.

Purpose of the Study:

  • To investigate how early antibiotic exposure impacts vaccine antibody titers at four months corrected age in preterm infants.
  • To explore potential sex-specific differences in these effects.

Main Methods:

  • Prospective observational study of 69 preterm infants (<32 weeks gestational age).
  • Analysis of vaccine titers (Bordetella pertussis, Haemophilus influenzae), immune cell profiles, gut microbiome composition, and metabolomics at postnatal day 14 and 4 months corrected age.
  • Comparison between infants with and without early antibiotic exposure.

Main Results:

  • Antibiotic-exposed preterm infants had reduced vaccine antibody titers, with a more pronounced effect in girls.
  • Antibiotic-exposed girls showed increased monocytes and myeloid-derived suppressor cells (MDSCs), inversely correlating with antibody titers.
  • Early antibiotics altered gut microbiome composition and led to distinct metabolomic profiles in girls, linked to immune cell changes.

Conclusions:

  • Early antibiotic exposure negatively affects vaccine responses in preterm infants, with potential sex-specific susceptibility.
  • Antibiotic-induced alterations in the microbiome and metabolome may promote immune-suppressive cell populations, potentially weakening adaptive immunity to vaccines.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Vaccinations01:51

Vaccinations

Overview
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...